Analyst Ratings February 10, 2026

Jefferies Sticks With Hold on PayPal, Keeps $40 Price Target Amid Take-Rate Pressure

Analyst note details product-level take-rate moves in Q4 and flags mix and service pricing as headwinds to transaction revenue

By Maya Rios PYPL
Jefferies Sticks With Hold on PayPal, Keeps $40 Price Target Amid Take-Rate Pressure
PYPL

Jefferies retained its Hold rating and $40.00 price target on PayPal (PYPL), after a close review of the company's transaction revenue disclosures. The firm’s product-level analysis shows mixed movements in take rates across branded checkout, Braintree and Venmo in Q4, while broader transaction take rates excluding hedges were pressured by shifts in mix, lower Xoom pricing and a revenue reclassification tied to Paidy. PayPal remains profitable with a P/E of 7.58 and 4.32% revenue growth over the last 12 months, even as several other analysts have trimmed ratings and price targets amid cooling branded checkout growth and executive changes.

Key Points

  • Jefferies maintained a Hold rating and a $40.00 price target on PayPal, with shares trading at $41.14.
  • Product-level analysis shows branded take rates down 3.5 basis points in Q4 year-over-year, while Braintree and Venmo take rates improved modestly.
  • Overall transaction take rates excluding hedges were pressured by a mix shift toward lower-yielding TPV, lower Xoom pricing, and a Paidy revenue reclassification. Sectors impacted include payments, fintech, e-commerce and merchant services.

Jefferies reaffirmed a Hold rating on PayPal Holdings Inc. and left its price target unchanged at $40.00 in a research note published Tuesday. At the time of the report, PayPal shares were trading at $41.14, slightly above the firm’s target, though market data suggests the stock may be materially undervalued on a Fair Value basis.

The Jefferies team examined PayPal’s 10-K disclosures related to transaction revenue to derive product-level take rates for the fourth quarter. Their calculations point to a modest contraction in branded take rates, which the firm estimates fell by 3.5 basis points year-over-year in Q4 versus roughly flat take-rate performance in Q3. Jefferies attributes this decline to volume-driven investments that tempered branded margins.

Not all payment products moved in the same direction. Braintree saw an improvement in take rates, rising by 3 basis points year-over-year in Q4 after a 2 basis point increase in Q3. Venmo likewise recorded a sequential uptick, with take rates climbing 4 basis points in Q4 compared with a 3 basis point gain in the prior quarter.

Despite those gains at Braintree and Venmo, Jefferies highlighted that overall transaction take rates excluding hedges faced downward pressure in Q4 from several specific factors. The firm cited a mix shift toward lower-yielding total payment volume - TPV - lower pricing for Xoom services, and a revenue reclassification connected to Paidy as contributors to the weaker take-rate profile.

Jefferies’ breakdown of PayPal’s transaction revenue components across its various payment platforms and services underscores both areas of resilience and clear structural challenges within the company’s revenue model. The note stresses that while certain product-level metrics improved, aggregate transaction revenue metrics remain strained by mix and pricing dynamics.

On fundamental measures, PayPal continues to show profitability and moderate top-line expansion. The firm reported a price-to-earnings ratio of 7.58 and revenue growth of 4.32% over the trailing twelve months. Management has also been actively repurchasing shares, according to market research referenced in the note, and supplemental research materials provide further analysis and additional strategic observations.

Recent industry commentary and analyst actions reflect broader investor scrutiny. PayPal experienced a slowdown in branded checkout growth, decelerating to 1% year-over-year in the fourth quarter of 2025, a trend that has prompted multiple analyst downgrades and cuts to price targets.

  • HSBC reduced its rating from Buy to Hold and lowered its price target to $47.00, citing concerns about e-commerce share losses.
  • Canaccord Genuity downgraded PayPal to Hold from Buy and trimmed its price target to $42.00, while noting the company’s strong cash flow.
  • RBC Capital kept an Outperform rating but reduced its price target to $59.00 following a sudden change in the CEO role.
  • Wells Fargo cut its price target to $48.00, pointing to execution concerns specific to PayPal.
  • Citizens moved PayPal to Market Perform, highlighting slowing checkout growth and forecasting a decline in transaction margin dollars in 2026.

Taken together, these analyst moves and the product-level take-rate analysis from Jefferies paint a picture of a payments business that remains profitable but faces meaningful near-term headwinds. The company’s capacity to stabilize take rates and arrest checkout growth deceleration will be central to how investors and sell-side analysts reassess forecasts and price targets in coming quarters.


Note: This article reports on analyst research and market disclosures and summarizes the data contained in those documents.

Risks

  • Continued slowdown in branded checkout growth, which could weigh on transaction volumes and merchant-related revenues - impacts payments and e-commerce sectors.
  • Ongoing pressure on transaction take rates from mix shifts and service pricing changes, potentially reducing transaction margin dollars - impacts fintech revenue and profitability metrics.
  • Operational or leadership disruptions, such as abrupt executive changes, that may affect execution and investor confidence - impacts corporate governance and equity valuations in financial services.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026